A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

NCT00816686 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Trial was terminated due to the need to re-formulate the study drug.

Conditions

Carcinoma, Renal Cell
Kidney Neoplasms
Kidney Diseases

Interventions

BIOLOGICAL: AGS-16M18

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]